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Abstract: Macrophages (Mj) as efficient phagocytes able to present the antigen and playing an effector 
role induce and orchestrate the immune response also through the release of soluble factors. Recently 
described T CD8+ cell-derived suppressive exosomes carrying miRNA-150, that act antigen-specifi-
cally, seem to inhibit murine contact sensitivity reaction indirectly by affecting antigen presenting 
cells, especially Mj. Present studies investigated the influence of suppressive exosomes on secretory 
activity of Mj assessed as their ability to generate reactive oxygen intermediates (ROIs), nitric oxide, 
cytokines as well as their viability and expression of antigen phagocytosis and presentation markers. 
Interestingly, in vivo and in vitro treatment of Mj with assayed hapten-specific exosomes affected only 
ROIs generation, significantly enhancing their production. Current results suggest that ROIs may 
participate in antigen-specific tolerance mechanism mediated by suppressive T lymphocyte-derived 
exosome-influenced Mj, by inhibition of effector T cell proliferation and induction of T regulatory 
lymphocytes. 
Key words: macrophages, reactive oxygen intermediates, exosomes, T suppressor lymphocytes, im-
mune suppression, immune tolerance, cytokines, nitric oxide.
INTRODUCTION
Macrophages (Mj) are the efficient phagocytes present in all body tissues that 
are responsible for anti-microbial response and clearance of cellular debris. Fur-
thermore, Mj as the antigen presenting and effector cells induce, orchestrate as 
well as regulate the adaptive immune response. The immune activity of these 
cells is inter alia mediated by soluble factors released after Mj activation. The 
composition of secreted factors mainly is conditioned by the actual phenotype of 
Mj, which is activated by various cell-influencing signals [1].
T suppressor factor (TsF) described to be able to inhibit hapten-induced con-
tact sensitivity response in mice was shown to impair Mj antigen-presenting 
capacity [2]. Furthermore, previous studies suggested that Mj after binding of 
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TsF may release a soluble factor termed macrophage suppressor factor (MSF) 
inhibiting CS effector cells in an antigen non-specific manner [3–5]. Recent 
studies defined TsF as miRNA-150 molecule carried by exosomes coated with 
hapten-specific antibody light chains [6–9]. The TsF exosomes were shown to 
bind to hapten, enabling their specific purification by antigen affinity column 
chromatography, and to act antigen-specifically mediating the immune tole-
rance. Noteworthy, tolerogenesis procedure leading to induction of suppressor 
T(Ts) cell release of hapten-specific TsF exosomes includes the intravenous ad-
ministration of hapten-conjugated syngeneic erythrocytes followed by contact 
immunization with the same hapten. The latter procedure activates the release 
of B1 cell-derived specific light chains that coat the suppressive, hapten-spe-
cific exosomes. However, it was also shown that intravenous administration 
of high dose of unlabelled syngeneic erythrocytes also induces T suppressor 
lymphocytes to release exosomes containing miRNA-150 that are not coated 
with antibody light chains but express similar suppressive activity in antigen 
non-specific immune assays [9]. These non-specific suppressive exosomes were 
termed Sham factor (SHAM-F).
Since TsF exosomes were previously suggested to affect the various immune 
functions of Mj [10], the present studies were aimed to investigate the influence 
of TsF exosomes on secretory activity of murine peritoneal Mj assayed as their 
ability to release cytokines, nitric oxide and reactive oxygen intermediates as 
well as to determine if exosome treatment affects the Mj viability along with the 
expression of markers of antigen phagocytosis and presentation. 
MATERIALS AND METHODS
Ten-week-old CBA/J mice were from breeding unit of Department of Immunology, 
Jagiellonian University Medical College and were treated according to the guide-
lines of Jagiellonian University Ethics Committee (approval number 39/2011). 
Each experiment was repeated at least twice and representative results were 
statistically analyzed and interpreted. 
Fluorescein isothiocyanate (FITC)-conjugated rat anti-mouse Mac-3 mAb, phy-
coerythrin (PE)-conjugated rat anti-mouse H2k, anti-mouse CD80, anti-mouse 
CD86, anti-mouse CD11b, anti-mouse CD14 and anti-mouse CD16/32 mAb, 
FITC-conjugated annexin V, propidium iodide (BD Pharmingen, San Diego, CA), 
oxazolone (Aldrich Chemical Company, Milwaukee, WI), picryl chloride (PCL, tri-
nitrophenol chloride, TNP-Cl) (Chemtronix, Swannanoa, NC), trinitrobenzene sul-
phonic acid (TNBSA) (Eastman Chemicals, Rochester, NY) were used.
Mishell-Dutton Medium (MDM), RPMI1640, minimal essential medium with 
amino acids, HEPES, cacodylic buffer, TRIS buffer, 2-mercaptoethanol, luminol, 
lucigenin, DMSO, mineral oil heavy fraction, zymosan (Sigma, St. Louis, MO), 
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fetal calf serum (FCS), Dulbecco’s phosphate buffered saline (DPBS), Pen-Strep, 
sodium pyruvate, L-glutamine (Gibco Life Technologies, Grand Island, NY), ace-
tone, ethanol, glucose, reagents for Griess reaction (P.O.Ch., Gliwice, Poland), 
heparin (Polfa, Warszawa, Poland), ethylenediaminetetraacetic acid (EDTA) (BDH, 
Pool, England) and lipopolysaccharide (LPS) (BIO-Whittaker, Walkersville, MD) 
were used.
Mouse TNF alpha ELISA Ready-SET-Go kit (sensitivity 8 pg/ml), Mouse IL-6 
ELISA Ready-SET-Go kit (sensitivity 4 pg/ml), Mouse IL-10 Platinum ELISA Test 
(sensitivity 5 pg/ml), Mouse TGF-beta1 Platinum ELISA Test (sensitivity 8 pg/ml) 
(eBioscience, San Diego, CA), Mouse IL-12p40 BD OptEIA Set (sensitivity 15.6 pg/
ml) (BD Bioscience, San Diego, CA) were used to measure cytokine concentration 
in cell culture supernatants.
Ts lymphocytes were induced by double i.v. injections of 0.2 ml of 10% su-
spension of hapten-labelled syngeneic erythrocytes on days 0 and 4 followed by 
contact immunization on shaved abdomen skin with 0.15 ml of hapten solution 
on day 9. Then, on day 11 spleens and lymph nodes were harvested to isolate 
Ts cells for 48-hour culture in MDM at concentration 2 × 107 cells/ml [9]. The 
released exosomes were isolated from culture supernatant (SN) by double ultra-
centrifugation at 100000 g for 70 minutes at 4oC after centrifugation at 300 g 
and 10000 g and filtration through 0.45 µm, 0.22 µm and 0.1 µm molecular 
filters. Pellet was then resuspended in DPBS [9] and used as hapten-specific 
suppressive exosomes. SHAM-F exosomes [9] were obtained as above from SN of 
culture of Ts cells induced by injection of unlabelled MRBC treated as for hapten 
conjugation and skin application of vehicle without hapten.
Mj were isolated as mineral oil-induced peritoneal exudate cells from either 
naive, hapten-contact immunized (Mj were then treated with exosomes in vitro 
for 30 minutes in 37oC water-bath followed by washing at 300 g) or tolerized 
mice (Mj treated with exosomes in vivo). In some instances exosome-treated Mj 
were labelled with TNP hapten by 10-minute incubation in darkness with TNBSA 
solution (2 mg/ml) in ratio 0.2 mg TNBSA per 107 cells.
Naive or tolerized donor-derived Mj treated with suppressive exosomes were 
assayed by flow cytofluorometric analysis (FACSCalibur, BD Biosciences, San 
Jose, CA, USA) for expression of H2k (MHC class II), CD80, CD86, CD11b, CD14, 
CD16/32 surface markers by staining with appropriate monoclonal antibodies 
as well as for their viability after staining with FITC-conjugated annexin V (for 
evaluation of apoptosis) and propidium iodide (for evaluation of necrosis).
After similar treatment with exosomes Mj unstimulated or stimulated with 
LPS (20 µl of 10 µg/ml solution per well) were cultured in standard conditions 
(2×106 cells per 2 ml per well) and resulting supernatants were collected 24 and 
48 hours later for measurement of concentration of nitric oxide in method based 
on Griess reaction [11] and selected cytokines in ELISA performed according to 
manufacturer procedures.
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The generation of ROIs by Mj in vivo and in vitro treated with exosomes was 
assessed in luminol- and lucigenin-dependent chemiluminescence after stimula-
tion of Mj oxidative burst with zymosan [12, 13].
RESULTS
THE RELEASE OF CYTOKINES AND NITRIC OXIDE BY CULTURED EXOSOME-TREATED MF
Treatment of Mj with suppressive exosomes did not significantly influence their 
unstimulated (Fig. 1a) or LPS-stimulated (Fig. 1b) ability to release nitric oxide 
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Fig. 1. Macrophages were harvested from naive mice and then treated in vitro with proper exosomes 
prior to cell culture of macrophages (at concentration 1 × 106 cells per ml) in indicated groups sti-
mulated with LPS (100 ng per 106 cells). Concentration of nitric oxide was measured in supernatant 
collected after 24 hours of cell culture and is expressed in µmoles.
a)
b)
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T a b l e  1
Release of pro- and anti-inflammatory cytokines by macrophages treated in vivo or in vitro with 
suppressive exosomes.
Cytokine
IL-6 TNFa IL-12p40 IL-10 TGF-b1
Macrophages
Mj [control] 56 8 39 19 893±67.0
Mj [control]+LPS 28006 1860 1110±311.4 378±20.2 642±76.2
Mj [TNP-TsF] 31 <4 34 <5 706±163.8
Mj [TNP-TsF]+LPS 25644 2755 1053±162.6 508±24.7 653±206.4
Mj [OX-TsF] 33 4 36 <5 728±177.1
Mj [OX-TsF]+LPS 17481 2572 ± 455.0 1147±218.3 525±35.4 559±158.1
Mj [SHAM-F] 115 11 62 <5 714±145.2
Mj [SHAM-F]+LPS 24625 2750 1124±175.2 355±7.1 494±48.0
TNP-Mj control 366±45.1 25±3.9 29±7.1 55±1.3 1136±68.2
TNP-Mj control+LPS 33809±4238.2 332±12.0 346±40.1 365±40.0 1356±220.8
TNP-Mj+TNP-TsF 653±3.5 33±1.8 25±2.8 56±6.8 1063±104.2
TNP-Mj+TNP-TsF+LPS 25741±587.8 348±7.1 379±22.5 331±25.9 1419±217.4
TNP-Mj+NF 1106±275.9 36±2.1 28±1.5 55±2.8 1652±205.1
TNP-Mj+NF+LPS 27622±1082.8 296±24.8 379±48.4 333±33.8 1781±412.6
Mj control 165±30.1 5±0.9 8±1.4 15±0.2 1289±131.3
Mj control+LPS 33331±13302.4 324±43.8 150±1.4 293±20.8 995±132.3
Mj+TNP-TsF 163±5.9 5±1.3 7±1.4 18±1.4 1498±85.9
Mj+TNP-TsF+LPS 30013±9970.2 223±10.0 126±7.1 245±57.7 1097±108.4
Mj+OX-TsF 200±51.2 <4 12±2.9 12±0.2 1412±101.7
Mj+OX-TsF+LPS 29341±1533.5 <4 164±11.3 201±27.5 1012±91.1
Mj+SHAM-F 156±55.1 5±0.64 10±2.8 13±0.2 1220±319.1
Mj+SHAM-F+LPS 24050±7663.3 286±10.6 145±2.8 208±14.7 1155±136.3
Mj+NF 235±14.2 7±1.4 14±0.8 12±0.2 1499±148.0
Mj+NF+LPS 26634±359.5 305±49.5 143±9.9 224±19.8 1043±129.3
First experiment: macrophages were harvested from either naive mice (Mj [control]) or from donors of exosomes 
of trinitrophenol-specific T suppressor factor (Mj [TNP-TsF]), oxazolone-specific TsF (Mj [OX-TsF]) or Sham factor 
(Mj [SHAM-F]). Second experiment: macrophages were harvested from naive donors and in vitro treated with exo-
somes of TNP-specific TsF (TNP-Mj + TNP-TsF) or negative factor (TNP-Mj + NF) followed by conjugation with TNP 
hapten. Third experiment: macrophages were harvested from naive mice and then treated in vitro with exosomes 
of TNP-specific TsF (Mj + TNP-TsF), OX-specific TsF (Mj + OX-TsF), Sham factor (Mj + SHAM-F) or negative fac-
tor (Mj + NF). Concentrations of tested cytokines are expressed in pg/ml of supernatant collected after 24 hours 
(IL-6, TNFa, IL-12p40) or 48 hours (IL-10, TGF-b1) of culture of macrophages (at concentration 1×106 cells per ml) 
in indicated groups stimulated with LPS (100 ng per 106 cells).
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into cell culture supernatant. Further, the unstimulated as well as LPS-stimu-
lated Mj secretion of pro-inflammatory TNFa, IL-6, IL-12p40 and anti-inflam-
matory IL-10, TGFb1 cytokines was not significantly affected by in vivo and in 
vitro suppressive exosome-treatment (Table 1). However, the inhibition of TNFa 
release by unstimulated and LPS-stimulated Mj treated with oxazolone-specific 
TsF exosomes was demonstrated. 
THE VIABILITY AND EXPRESSION OF SURFACE MARKERS OF MF TREATED WITH EXOSOMES
In vivo and in vitro treatment of Mj with assayed suppressive exosomes did 
not significantly alter the cytofluorometrically analyzed expression of markers of 
antigen phagocytosis (CD11b, CD14, CD16/32) and presentation (MHC class II, 
CD80, CD86) (Table 2a). However, apart from CD11b-expressing cells, the slight 
decrease in the number of Mac-3+ cells with the expression of analyzed markers 
was assessed. Further, despite the lack of significant differences in viability, the 
increased ratio of apoptotic to necrotic cells was observed in case of suppressi-
ve exosome-treated Mj with the strongest effect caused by SHAM-F exosomes 
(Table 2b).
T a b l e  2a
Percentage of macrophages expressing specific surface markers of antigen phagocytosis  
(CD11b, CD14, CD16/32) and presentation (MHC class II, CD80, CD86).
Marker
Macrophages
CD11b CD14 CD16/32 MHC II CD80 CD86
Mj  total 96.4 25.8 61.2 45.3 84.9 57.1
Mj  Mac-3+ 62.4 14.6 22.1 22.8 13.0 16.6
Mj  total + TNP-TsF 97.0 28.6 62.5 47.4 84.7 56.3
Mj  Mac-3+ + TNP-TsF 43.3 8.7 12.3 11.5 5.9 6.3
Mj  total [TNP-TsF] 92.9 35.6 83.9 81.2 87.8 83.3
Mj  Mac-3+ [TNP-TsF] 48.2 22.6 24.9 35.0 25.5 28.1
Mj  total [SHAM-F] 93.3 40.0 77.4 73.1 89.8 76.6
Mj  Mac-3+ [SHAM-F] 45.2 25.3 27.6 34.2 24.2 26.2
PCL-Mj  total 87.8 45.4 81.5 93.6 85.7 85.2
PCL-Mj  Mac-3+ 10.5 37.2 35.9 40.9 34.0 34.3
First experiment: macrophages were harvested from naive mice (Mj) and treated in vitro with exosomes of TNP-spe-
cific suppressor factor (Mj + TNP-TsF). Second experiment: macrophages were harvested either from mice contact 
sensitized with picryl chloride (PCL-Mj) or from donors of exosomes of TNP-specific TsF (Mj [TNP-TsF]) or Sham 
factor (Mj [SHAM-F]). Macrophages were analyzed as total population of harvested viable cells (Mj total), that did 
not bind propidium iodide, or as cells expressing Mac-3 marker (Mj Mac-3+).
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T a b l e  2b
Assessment of viability of exosome-treated macrophages as percentage of cells binding annexin V 
(AnnV+) and/or propidium iodide (PI+).
Mj Mj  + TNP-TsF Mj  [TNP-TsF] Mj  [SHAM] PCL-Mj
PI+ 
(necrosis)
18.6 12.9 6.7 10.8 3.9
AnnV+ 
(early apoptosis)
6.4 9.2 22.2 16.7 29.2
PI+AnnV+ 
(late apoptosis)
8.8 12.0 15.1 20.3 9.0
Total % 33.4 34.1 44 47.8 42.1
First experiment: macrophages were harvested from naive mice (Mj ) and treated in vitro with exosomes of TNP-spe-
cific suppressor factor (Mj  + TNP-TsF). Second experiment: macrophages were harvested either from mice contact 
sensitized with picryl chloride (PCL-Mj ) or from donors of exosomes of TNP-specific TsF (Mj  [TNP-TsF]) or Sham 
factor (Mj  [SHAM-F]).
GENERATION OF ROIS BY EXOSOME-TREATED MF
The significant enhancement of zymosan-activated generation of ROIs by Mj col-
lected from tolerized donors was observed in luminol- and lucigenin-dependent 
chemiluminescence assays, in which oxidative burst was activated either just after 
(Fig. 2a and 2b) or 24 hours after collection of Mj (Fig. 2c and 2d). Similarly, 
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Fig. 2a. Luminol-dependent chemiluminescence measurement of reactive oxygen intermediates generation 
by macrophages (1×106 cells per well) harvested from naive mice (Mf ctrl) or donors of exosomes of 
either Sham factor (Mf SHAM-F), trinitrophenol-specific T suppressor factor (Mf TNPTsF) or oxazolone- 
specific TsF (Mf OXTsF). ROIs production was stimulated just after harvest of macrophages with 
zymosan (50 µl). Results are expressed in relative units of luminescence emission (RULE).
44
0 1000 2000 3000 4000 5000
0
500
1000
1500
2000
2500
LUMINOL
 Mf ctrl
 Mf ctrl + zymosan
 Mf SHAM-F 
 Mf SHAM-F + zymosan
 Mf TNP-TsF 
 Mf TNP-TsF + zymosan
 Mf OX-TsF
 Mf OX-TsF + zymosan
RU
LE
TIME [s]
Fig. 2b. Lucigenin-dependent chemiluminescence measurement of reactive oxygen intermediates 
generation by macrophages (1×106 cells per well) harvested from naive mice (Mf ctrl) or donors of 
exosomes of either Sham factor (Mf SHAM-F), trinitrophenol-specific T suppressor factor (Mf TNPTsF) 
or oxazolone-specific TsF (Mf OXTsF). ROIs production was stimulated just after harvest of macrophages 
with zymosan (50 µl). Results are expressed in relative units of luminescence emission (RULE).
Fig. 2c. Luminol-dependent chemiluminescence measurement of reactive oxygen intermediates generation 
by macrophages (1×106 cells per well) harvested from naive mice (Mf ctrl) or donors of exosomes of 
either Sham factor (Mf SHAM-F), trinitrophenol-specific T suppressor factor (Mf TNPTsF) or oxazolone- 
specific TsF (Mf OXTsF). ROIs production was stimulated after 24 hour culture of macrophages with 
zymosan (50 µl). Results are expressed in relative units of luminescence emission (RULE).
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Fig. 2d. Lucigenin-dependent chemiluminescence measurement of reactive oxygen intermediates 
generation by macrophages (1×106 cells per well) harvested from naive mice (Mf ctrl) or donors of 
exosomes of either Sham factor (Mf SHAM-F), trinitrophenol-specific T suppressor factor (Mf TNPTsF) 
or oxazolone-specific TsF (Mf OXTsF). ROIs production was stimulated after 24 hour culture of macro-
phages with zymosan (50 µl). Results are expressed in relative units of luminescence emission (RULE).
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Fig. 3a. Luminol-dependent chemiluminescence measurement of zymosan-stimulated reactive oxygen 
intermediates generation by macrophages (1×106 cells per well) harvested from either naive mice 
(Mf control) or mice contact sensitized with picryl chloride (PCLMf control) that were then in vitro 
treated with exosomes of trinitrophenol-specific T suppressor factor (Mf & TNP-TsF EXOS; PCLMf & 
TNP-TsF EXOS) or negative factor (Mf & NF EXOS; PCLMf & NF EXOS). Results are expressed in 
relative units of luminescence (RUL).
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treatment of oil-induced peritoneal Mj harvested from either naive or PCL hapten 
contact immunized donors with suppressive TsF and SHAM-F exosomes also re-
sulted in increased generation of ROIs (Fig. 3a and 3b). Interestingly, the chemilu-
minescence signal was higher for Mj from naive mice in comparison to immunized 
mice. The results suggest that ROIs as the only one of tested factors released by 
Mj may participate in investigated antigen-specific suppression mechanism.
DISCUSSION
Results of Ptak et al. [2, 4, 5, 10] suggested that TsF released by T CD8+ lympho-
cytes inhibits murine contact sensitivity reaction through the action on antigen 
presenting Mj that then transmit regulatory signal to effector cells of immune 
response. Moreover, Mj were shown to be able to bind TsF, which activated their 
release of secondary suppressor factor termed as macrophage suppressor factor 
(MSF) [3, 5, 14, 15]. Recently, our research group identified TsF as miRNA-150 
secreted by Ts lymphocytes in exosomes coated with B1 cell-derived hapten speci-
fic antibody light chains [6–9]. This allowed to re-investigate previously described 
mechanism of TsF activity. The ability of Mj to induce adaptive immune respon-
se also depends on expression of markers involved in antigen engulfment and 
presentation as well as on soluble factors released by Mj, including cytokines, 
Fig. 3b. Lucigenin-dependent chemiluminescence measurement of zymosan-stimulated reactive oxy-
gen intermediates generation by macrophages (1×106 cells per well) harvested from either naive mice 
(Mf control) or mice contact sensitized with picryl chloride (PCLMf control) that were then in vitro 
treated with exosomes of trinitrophenol-specific T suppressor factor (Mf & TNP-TsF EXOS; PCLMf & 
TNP-TsF EXOS) or negative factor (Mf & NF EXOS; PCLMf & NF EXOS). Results expressed in relative 
units of luminescence (RUL).
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nitric oxide and ROIs. Therefore, the present studies were aimed to determine if 
treatment of Mj with TsF exosomes influence their secretory activity, expression 
of specific surface markers and viability.
Firstly, the unstimulated and stimulated with pathogen associated molecular 
patterns (PAMPs) secretory activity of Mj was assessed after either in vivo or in 
vitro treatment of tested cells with suppressive TsF or SHAM-F exosomes. The 
zymosan-stimulated generation of ROIs by Mj harvested from naive or hapten 
contact immunized donors as well as from tolerized mice that were induced for 
Ts cell release of TsF was measured in the luminol and lucigenin dependent che-
miluminescence assay. Noteworthy, luminol may cross cellular membrane, which 
allows to measure both, extra- and intracellular pools of ROIs, while lucigenin is 
oxidized only by extracellular ROIs [12, 13, 16, 17]. 
The significant enhancement of intra- and extracellular ROIs generation was 
observed under the influence of hapten (either trinitrophenol or oxazolone) speci-
fic TsF and SHAM-F exosomes when peritoneal Mj were obtained from tolerized 
donors (Fig. 2a and 2b). Interestingly, the same effect was observed even when 
Mj oxidative burst was stimulated with zymosan after 24 hour culture of Mj 
(Fig. 2c and 2d). However, after cell culture the chemiluminescence signal was 
reduced, which suggested the diminished metabolic activity and viability of Mj. 
Similarly, the increased generation of ROIs was observed as a result of in vitro 
treatment of Mj from naive or PCL contact sensitized mice with TNP-specific 
TsF exosomes (Fig. 3a and 3b). Furthermore, the chemiluminescence signal was 
reduced in case of Mj collected from sensitized donors in comparison to naive 
mice, which suggests that previous contact with hapten may influence the Mj 
inflammatory response to stimulation with PAMPs. 
Current observations suggest that TsF exosomes do not affect phagocytic acti-
vity of Mj. However, Blackstock et al. [18] determined the reduced phagocytosis of 
bacterial antigens by Mj incubated with supernatant containing crude TsF, which 
may be the result of unspecific inhibition of phagocytosis during the engulfment of 
TsF by Mj. Nevertheless, the presently observed enhancement of ROIs generation 
by suppressive exosome-treated Mj could increase their cytotoxic activity. In de-
layed-type hypersensitivity (DTH), including CS, Mj apart from antigen-presenting 
capability, express effector cytotoxic activity, which during the sterile, non-rela-
ted to infection, inflammatory response is directed against effector lymphocytes 
leading to the inhibition of their proliferation and differentiation. This in turn 
suppresses the effector immune response enabling alleviation of allergic clinical 
symptoms. Tripathi and Hildeman [19] described one of the naturally occurring 
mechanisms of the limitation of the active immune reaction involving induction 
of T effector cell apoptosis by ROIs generation, which results in inhibition of 
T cell expansion and in survival of only the memory T lymphocytes. Worth to note 
is that ROIs express very short biological half-life and their activity is limited to 
the cells in the nearest neighborhood of Mj [20]. Thus, it may be directed aga-
48
inst T lymphocyte recognizing hapten presented by Mj [20, 21] to mediate the 
suppressive effect of TsF exosomes. Additionally, ROIs generated by Mj may also 
affect their intracellular signalization pathways [22]. However, antigen presenting 
cell-derived ROIs along with cytokines were also shown as activators of effector 
response in immunological synapse [23]. On the other hand, knock-out mice that 
are unable to generate ROIs after stimulation express increased susceptibility 
to develop autoimmune response [24]. Moreover, generation of ROIs by Mj was 
shown to express protective effect associated with the activation of T regulatory 
lymphocytes in a course of rheumatoid arthritis [25, 26]. This may suggest that 
presently observed enhancement of ROIs generation by Mj treated with suppres-
sive TsF exosomes may also lead to development of T regulatory cells mediating 
the specific suppression of immune response.
Apart from ROIs, also nitric oxide is an efficient mediator of the cytotoxic 
response of Mj. However, in vitro treatment of Mj with hapten-specific TsF or 
SHAM-F exosomes did not significantly affect their ability to secrete nitric oxide 
(Fig. 1a and 1b). Macrophage-derived nitric oxide mediates intracellular pathogen
-induced DTH reaction, which seems to confirm that TsF exosomes do not impair 
phagocytic and anti-microbial activity of Mj. Further, nitric oxide was identified 
as a potent immunoregulatory factor involved in the suppression of T cell-depen-
dent immunity [27–30], including CS [31]. Therefore, TsF exosomes possibly do 
not influence nitric oxide-dependent mechanisms of immunoregulation.
Cytokines are the further assayed secretory factors that mediate and orche-
strate Mj antigen non-specific immune activity. Present results showed that in 
vivo and in vitro treatment of Mj with suppressive TsF and SHAM-F exosomes 
does not significantly influence their unstimulated or LPS-stimulated release of 
pro-inflammatory IL-6, TNFa, IL-12p40 as well as anti-inflammatory IL-10 and 
TGF-b1 cytokines into culture supernatant (Table 1). The observed inhibition of 
macrophage-activating TNFa release by Mj treated with oxazolone-specific TsF 
exosomes may result from difference in mechanism of CS induced by this hapten, 
which is mediated by T CD8+ cytotoxic lymphocytes rather than Th1 cells and 
Mj [32]. Since anti-inflammatory cytokine activity suppresses the response in an 
antigen non-specific manner, the observed results seem to confirm antigen-spe-
cific mechanism of action of TsF exosomes through Mj, Moreover, it was shown 
recently that treatment of patients with recombinant IL-10 leads to development 
of antigen non-specific immune suppression due to the inhibition of expression 
of co-stimulatory molecules on the surface of antigen presenting cells [33].
To test the potential involvement of alteration of Mj surface markers expres-
sion mediating antigen phagocytosis and presentation in presently studied tole-
rance mechanism, we have analyzed cytofluorometrically the expression of CD11b, 
CD14, CD16/32, CD80, CD86 and MHC class II on the surface of Mj treated 
either in vivo or in vitro with TsF or SHAM-F exosomes. Interestingly, the analysis 
failed to show significant differences in the expression of tested markers on the 
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surface of total population of assayed cells as well as of the Mac-3+ population 
of pro-inflammatory Mj [12] under the influence of exosomes (Table 2a), which 
confirms aforementioned high specificity of investigated TsF exosome-dependent 
suppression mechanism. This further allows to avoid the bystander antigen ef-
fect often observed in immune suppression induced by non-specific blocking of 
antigen presentation. Recently, Mi et al. described the impairment of antigen pre-
senting capacity of Langerhans cells in miRNA-150 knock-out mice. However, the 
expression of markers of antigen phagocytosis and presentation was comparable 
to these assessed in wild type mouse Langerhans cells [34]. Present and latter 
results suggests that miRNA-150 does not affect the phenotype of Mj defined as 
the expression of specific functional markers.
Further, the viability of Mj treated in vivo and in vitro with suppressive exo-
somes was assessed as the percentage of cells binding FITC-conjugated annexin 
V and/or propidium iodide [35, 36], wherein the cells that bound only either the 
annexin V or propidium iodide were considered as, subsequently, early apoptotic 
or necrotic and cells that bound both dyes as late apoptotic. 
Although treatment of Mj with TsF and SHAM-F exosomes did not influence 
their viability, we observed the increase of the late apoptotic cell percentage in 
the total analyzed population of Mj (Table 2b). This suggests that suppressive 
exosomes may promote the apoptotic cell death rather than necrosis to then 
prevent the development of inflammation and autoimmunization as well.
To summarize, our results indicate that TsF exosome-mediated immune sup-
pression could be mediated by macrophage-derived ROIs, suggesting their involve-
ment in antigen-specific immune tolerance mechanism. Mj releasing ROIs may 
therefore inhibit the proliferation of effector T cells as well as induce the regulatory 
phenotype of naive T lymphocytes, leading to alleviation of clinical symptoms of 
allergic cellular immune response observed in mice under the influence of T CD8+ 
cell-derived suppressive exosomes. However, our preliminary data suggest the re-
lease of MSF-remaining factor by Mj treated with TsF exosomes [37], which, apart 
from or together with ROIs, may mediate the studied suppression mechanism. 
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Mj — macrophages 
MSF — macrophage suppressor factor 
NF — negative factor 
OX-TsF — oxazolone-specific T suppressor factor 
SHAM-F — control Sham factor 
TNP-TsF — trinitrophenol-specific T suppressor factor 
TsF — T suppressor factor
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